ULTRAGENYX PHARMACEUTICAL INC. Property, Plant and Equipment, Gross
ULTRAGENYX PHARMACEUTICAL INC. (RARE) had Property, Plant and Equipment, Gross of $380.00 million as of 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-02-18
- 2025-12-31: Property, Plant and Equipment, Gross $380.00M.
- 2024-12-31: Property, Plant and Equipment, Gross $378.00M; Property, Plant and Equipment, Gross as first filed $378.41M.
- 2023-12-31: Property, Plant and Equipment, Gross $373.97M.
- 2022-12-31: Property, Plant and Equipment, Gross $323.11M.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2025-12-31 | $380.00M 10-K · filed 2026-02-18 | |
| 2024-12-31 | $378.00M 10-K · filed 2026-02-18 | $378.41M 10-K · filed 2025-02-19 |
| 2023-12-31 | $373.97M 10-K · filed 2025-02-19 | |
| 2022-12-31 | $323.11M 10-K · filed 2024-02-21 | |
| 2021-12-31 | $191.28M 10-K · filed 2023-02-17 | |
| 2020-12-31 | $110.91M 10-K · filed 2022-02-15 | |
| 2019-12-31 | $70.34M 10-K · filed 2021-02-12 | |
| 2018-12-31 | $38.25M 10-K · filed 2020-02-14 | |
| 2017-12-31 | $32.83M 10-K · filed 2019-02-20 | |
| 2016-12-31 | $23.22M 10-K · filed 2018-02-21 | |
| 2015-12-31 | $10.24M 10-K · filed 2017-02-17 | |
| 2014-12-31 | $4.51M 10-K · filed 2016-02-26 | |
| 2013-12-31 | $2.12M 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |